Sclafani F - Search Results

1

Preexisting evidence and outcome of phase III trials in gastrointestinal oncology: a systematic review.

Bregni G, Trevisi E, Saúde Conde R, Vanhooren M, Akin Telli T, Assaf I, Hendlisz A, Di Maio M, Sclafani F. Bregni G, et al. Among authors: sclafani f. J Natl Cancer Inst. 2023 May 8;115(5):505-513. doi: 10.1093/jnci/djad030. J Natl Cancer Inst. 2023. PMID: 36762842 Free PMC article.

2

Pre-trial quality assurance of diffusion-weighted MRI for radiomic analysis and the role of harmonisation.

Paquier Z, Chao SL, Bregni G, Sanchez AV, Guiot T, Dhont J, Gulyban A, Levillain H, Sclafani F, Reynaert N, Bali MA. Paquier Z, et al. Among authors: sclafani f. Phys Med. 2022 Nov;103:138-146. doi: 10.1016/j.ejmp.2022.10.009. Epub 2022 Oct 27. Phys Med. 2022. PMID: 36308999 Free article.

3

The emerging role of immunotherapy in the treatment of anal cancer.

Saúde-Conde R, Parisi A, Giunta EF, Meyers M, Sclafani F. Saúde-Conde R, et al. Among authors: sclafani f. Curr Opin Pharmacol. 2022 Dec;67:102309. doi: 10.1016/j.coph.2022.102309. Epub 2022 Oct 27. Curr Opin Pharmacol. 2022. PMID: 36334330 Review.

4

Regorafenib Induces Senescence and Epithelial-Mesenchymal Transition in Colorectal Cancer to Promote Drug Resistance.

Kehagias P, Kindt N, Krayem M, Najem A, Agostini G, Acedo Reina E, Bregni G, Sclafani F, Journe F, Awada A, Ghanem GE, Hendlisz A. Kehagias P, et al. Among authors: sclafani f. Cells. 2022 Nov 18;11(22):3663. doi: 10.3390/cells11223663. Cells. 2022. PMID: 36429091 Free PMC article.

5

The Prognostic Value of Distinct Histological Growth Patterns of Colorectal Peritoneal Metastases: A Pilot Study.

El Asmar A, Demetter P, Fares F, Sclafani F, Hendlisz A, Donckier V, Vermeulen P, Liberale G. El Asmar A, et al. Among authors: sclafani f. Ann Surg Oncol. 2023 Jun;30(6):3320-3328. doi: 10.1245/s10434-023-13118-x. Epub 2023 Feb 8. Ann Surg Oncol. 2023. PMID: 36754942 Free PMC article.

6

[No title available]

[No authors listed] [No authors listed] PMID: 36867176

7

Neoadjuvant chemotherapy for resectable colon cancer in the era of precision oncology: a step forward or a step back?

Audisio A, Fazio R, Hendlisz A, Sclafani F. Audisio A, et al. Among authors: sclafani f. Curr Opin Oncol. 2023 Jul 1;35(4):315-317. doi: 10.1097/CCO.0000000000000945. Curr Opin Oncol. 2023. PMID: 37285030 No abstract available.

8

Prognostic Value of Circulating Cytokines in Chemorefractory Colorectal Cancer.

Assaf I, Fimereli D, Anthoine G, Fazio R, Daprà V, Audisio A, Bardiaux A, Telli TA, Vanhooren M, Saude-Conde R, Bregni G, Hendlisz A, Sclafani F. Assaf I, et al. Among authors: sclafani f. Cancers (Basel). 2023 Dec 13;15(24):5823. doi: 10.3390/cancers15245823. Cancers (Basel). 2023. PMID: 38136368 Free PMC article.

9

Neoadjuvant chemotherapy for early-stage colon cancer.

Audisio A, Fazio R, Daprà V, Assaf I, Hendlisz A, Sclafani F. Audisio A, et al. Among authors: sclafani f. Cancer Treat Rev. 2024 Feb;123:102676. doi: 10.1016/j.ctrv.2023.102676. Epub 2023 Dec 23. Cancer Treat Rev. 2024. PMID: 38160535 Review.

10

Primary resistance to immunotherapy in patients with a dMMR/MSI metastatic gastrointestinal cancer: who is at risk? An AGEO real-world study.

Flecchia C, Auclin E, Alouani E, Mercier M, Hollebecque A, Turpin A, Mazard T, Pernot S, Dutherage M, Cohen R, Borg C, Hautefeuille V, Sclafani F, Ben-Abdelghani M, Aparicio T, De La Fouchardière C, Herve C, Perkins G, Heinrich K, Kunzmann V, Gallois C, Guimbaud R, Tougeron D, Taieb J. Flecchia C, et al. Among authors: sclafani f. Br J Cancer. 2024 Feb;130(3):442-449. doi: 10.1038/s41416-023-02524-3. Epub 2023 Dec 15. Br J Cancer. 2024. PMID: 38102227

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

115 results

Search Page